carpal tunnel syndrome. carpal tunnel syndrome
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Inclusion criteria: Patients of both sexes in the age range of 20 to 60 years; clinically diagnosed CTS by a specialist; confirmed mild to moderate CTS by electrodiagnosis report; signing the informed consent form and accept the terms of participation in the study. Exclusion criteria: the inability to filling forms (mental disability or speech impairment); history of trauma or surgery in carpal tunnel region or direct injection into the tunnel of carp; pregnancy; history of diabetes and thyroid disorders announced by the patient; median nerve involvement in areas other than the carpal region that is established with the clinical diagnosis and NCV; history of collagen vascular diseases such as rheumatoid arthritis, scleroderma, amyloidosis, lupus and synchronization with other tenosynovitis certified by rheumatologist; history of dermal reaction due to the use of local products; history of allergy to topical or oral compositions of linen; recent cancer chemotherapy and radiotherapy; taking corticosteroids, immunosuppressants and cytotoxic agents; serious medical conditions such as kidney or heart failure or cancer; pathological obesity or leanness (based on BMI); thenar muscle atrophy; permanent paresthesia; severe type of CTS in NCV.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sensory symptoms in CTS. Timepoint: 3 week. Method of measurement: standard Boston questionnaire.;Functional status of hand. Timepoint: 3 week. Method of measurement: standard Boston questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Local side effect of topical gel. Timepoint: first day, end of third week. Method of measurement: history and clinical examination. | — |
Countries
Iran (Islamic Republic of)
Contacts
Tehran University of Medical Science